References
- Clemmensen K, Akrawi N, Stawowy M. Irreversible optic neuritis after infliximab treatment in a patient with ulcerative colitis. Scand J Gastroenterol. 2015;50:1508–1511.
- Pastor GA, Garcia Medina JJ. Neuropatía óptica anterior unilateral asociada a Infliximab [Unilateral Anterior optic neuropathy associated to infliximab]. 88th Congress of the Spanish Society of Ophthalmology. Barcelona, 26–29 September 2012. [cited 2015 Nov 21]. Available from: http://web.archive.org/web/20121222112625/ http://www.oftalmo.com/88congresoseo/programa_casos_clinicos.htm.
- Silva LC, Ortigosa LC, Benard G. Anti-TNF-α agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls. Immunotherapy. 2010;2:817–833.
- Li SY, Birnbaum AD, Goldstein DA. Optic neuritis associated with adalimumab in the treatment of uveitis. Ocul Immunol Inflamm. 2010;18:475–481.
- Chan JW, Castellanos A. Infliximab and anterior optic neuropathy: case report and review of the literature. Graefes Arch Clin Exp Ophthalmol. 2010;248:283–287.
- Grzybowski A, Zülsdorff M, Wilhelm H, et al. Toxic optic neuropathies: an updated review. Acta Ophthalmol. 2015;93:402–410.
- Mozaffari S, Nikfar S, Abdolghaffari AH, et al. New biologic therapeutics for ulcerative colitis and Crohn’s disease. Expert Opin Biol Ther. 2014;14:583–600.
- Nakamura S, Matsumoto T. Gastrointestinal lymphoma: recent advances in diagnosis and treatment. Digestion. 2013;87:182–188.
- Czaja AJ. Current and prospective pharmacotherapy for autoimmune hepatitis. Expert Opin Pharmacother. 2014;15:1715–1736.
- Hart PA, Zen Y, Chari ST. Recent advances in autoimmune pancreatitis. Gastroenterology. 2015;149:39–51.